AREXVY is a vaccine indicated for active immunization for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV).

PRODUCT FEATURES:

Blenrep (belantamab mafodotine-awof) is a monoclonal antibody designed to treat multiple myeloma, a type of cancer that affects plasma cells.

• Targets Multiple Myeloma Cells: Blenrep specifically targets a protein called BCMA, which is found on the surface of multiple myeloma cells.
• Triggers Immune System Response: Once attached to BCMA, Blenrep recruits other immune cells to help destroy the cancer cells.
• Approved for Relapsed/Refractory Multiple Myeloma: Blenrep is indicated for adults with multiple myeloma who have received at least three prior lines of therapy.
• Potential for Improved Outcomes: In clinical studies, Blenrep has shown promising results in terms of response rates and progression-free survival.

Cabenuva is a long-acting injectable medication used to treat HIV-1 infection in adults. It's a combination of two antiretroviral drugs: cabotegravir and rilpivirine.

Key features:

• Long-acting: Cabenuva is administered as an injection every two months, providing long-term HIV suppression without daily oral medication.
• Effective: Clinical trials have shown Cabenuva to be highly effective in suppressing HIV-1 viral load to undetectable levels.
• Convenient: The long-acting nature of Cabenuva reduces the need for daily medication, improving adherence and potentially reducing the risk of transmission.
• Suitable for people living with HIV: Cabenuva is approved for adults living with HIV-1 who are virologically suppressed and have no history of treatment failure.

Combivir is a fixed-dose combination medication used to treat HIV-1 infection. It contains two antiretroviral drugs: zidovudine and lamivudine.

Key features:

• Fixed-dose combination: Combivir provides both zidovudine and lamivudine in a single pill, making it convenient for patients.
• Oral administration: Combivir is taken by mouth, making it a relatively easy medication to use.
• Effective: Combivir has been shown to be effective in suppressing HIV-1 viral load to undetectable levels when used as part of a combination therapy regimen.
• Suitable for treatment-naive and treatment-experienced patients: Combivir can be used in both people who are newly diagnosed with HIV and those who have already received treatment.
• Potential side effects: Like other medications, Combivir can cause side effects. Common side effects may include nausea, headache, fatigue, and changes in body fat distribution.

Dovato is a fixed-dose combination medication used to treat HIV-1 infection in adults. It contains two antiretroviral drugs: dolutegravir and lamivudine.

Epivir is a brand name for the antiretroviral drug zidovudine. It's used to treat HIV-1 infection, a virus that attacks the immune system.

Key features:

• Antiretroviral drug: Zidovudine is a nucleoside reverse transcriptase inhibitor (NRTI), which works by blocking the enzyme that HIV-1 uses to replicate itself.
• Oral administration: Epivir is taken by mouth, making it a relatively easy medication to use.
• Effective: Epivir has been shown to be effective in suppressing HIV-1 viral load to undetectable levels when used in combination with other antiretroviral drugs.
• Suitable for treatment-naive and treatment-experienced patients: Epivir can be used in both people who are newly diagnosed with HIV and those who have already received treatment.

Epzicom/Kivexa is a fixed-dose combination medication used to treat HIV-1 infection in adults. It contains two antiretroviral drugs: abacavir and lamivudine.

Key features:

• Fixed-dose combination: Epzicom/Kivexa provides both abacavir and lamivudine in a single pill, making it convenient for patients.
• Oral administration: Epzicom/Kivexa is taken by mouth, making it a relatively easy medication to use.
• Effective: Epzicom/Kivexa has been shown to be effective in suppressing HIV-1 viral load to undetectable levels when used in combination with other antiretroviral drugs.
• Suitable for treatment-naive and treatment-experienced patients: Epzicom/Kivexa can be used in both people who are newly diagnosed with HIV and those who have already received treatment.

Jemperli (dostarlimab) is a monoclonal antibody used to treat certain types of cancer.

Key features of Jemperli:

• Effective treatment: Jemperli has shown promising results in clinical trials for the treatment of endometrial and rectal cancer.
• Can be used alone or in combination: Jemperli can be used alone or in combination with other treatments, depending on the specific type of cancer and the patient's individual situation.
• Potential side effects: Like any medication, Jemperli can cause side effects. Common side effects may include fatigue, diarrhea, nausea, and skin rash

Juluca is a fixed-dose combination medication used to treat HIV-1 infection in adults. It contains two antiretroviral drugs: dolutegravir and rilpivirine.

KEY FEATURES:

Lexiva/Telzir is a brand name for the antiretroviral drug fosamprenavir. It's used to treat HIV-1 infection, a virus that attacks the immune system.

Key features :

• Antiretroviral drug: Fosamprenavir is a protease inhibitor, which works by blocking the enzyme that HIV-1 uses to replicate itself.
• Oral administration: Lexiva/Telzir is taken by mouth, making it a relatively easy medication to use.
• Effective: Lexiva/Telzir has been shown to be effective in suppressing HIV-1 viral load to undetectable levels when used in combination with other antiretroviral drugs.
• Suitable for treatment-naive and treatment-experienced patients: Lexiva/Telzir can be used in both people who are newly diagnosed with HIV and those who have already received treatment.

Nucala is the brand name for the medication mepolizumab. It is a prescription drug used to treat certain respiratory conditions

KEY FEATURES:

• Targeted Therapy: Nucala specifically targets eosinophils, which are elevated in patients with eosinophilic asthma.
• Reduces Asthma Attacks: Can reduce the number of asthma attacks and improve lung function.
• Improves Quality of Life: Can improve the overall quality of life for patients with severe eosinophilic asthma.
• Administration: It's administered as a subcutaneous injection every 4 weeks.

Retrovir (zidovudine) is a medication used in the treatment of HIV/AIDS. It's a nucleoside reverse transcriptase inhibitor (NRTI), which means it works by blocking the enzyme HIV uses to replicate itself.

KEY FEATURES:

Selzentry/Celsentri (maraviroc) is a medication used in the treatment of HIV/AIDS. It's a CCR5 antagonist, which means it works by blocking the CCR5 receptor on the surface of immune cells, preventing HIV from entering these cells.

KEY FEATURES:

Tivicay (dolutegravir) is a medication used in the treatment of HIV/AIDS. It's an integrase inhibitor, which means it works by blocking the enzyme HIV uses to integrate its genetic material into the host cell's DNA.

KEY FEATURES:

Triumeq is a fixed-dose combination (FDC) medication used in the treatment of HIV/AIDS. It contains three antiretroviral drugs: dolutegravir (an integrase inhibitor), abacavir (a nucleoside reverse transcriptase inhibitor), and lamivudine (another nucleoside reverse transcriptase inhibitor).

KEY FEATURES:

• HIV Treatment: Triumeq is a crucial component of antiretroviral therapy (ART), a combination of medications used to manage HIV infection.
• Fixed-Dose Combination: It combines three antiretroviral drugs in a single pill, making it convenient for patients.
• Mechanism of Action: Each component drug has a different mechanism of action, working together to suppress HIV replication.